HKEX Insider Activity — 2026-09-11

by hk-insider-activities-daily

🇭🇰 HKEX DI Report — 2026-09-11

🟢 ACCUMULATING — 1091 South Manganese Investment ← Guoping Li (via Hanbo Global Inc.), 16.67% stake (new position, built from ~0%; bought 987,396,192 shares @ HKD 0.314 for HK$310.0M total) Read: A HK$310M block purchase hands Guoping Li a controlling-scale 16.67% stake in one shot — about as loud an insider-confidence signal as a micro-cap manganese name gets.

🆕 NEW ENTRY — 3860 EPS Creative Health Technology Group ← Ken Kaku, individual stake 22.32% / aggregate (incl. related interest) 25.86% (both new, first crossing 5%; 130,000,000 shares @ HKD 0.63 for HK$81.90M total) Read: A founder-level holder just locked down over a quarter of this small-cap health-tech name — a highly concentrated bet worth tracking for further buying.

🆕 NEW ENTRY — 9626 Bilibili ← UBS Group, 6.98% (increased by 2.20pp from prior filing; bought 7,592,385 shares @ HKD 116.51 for HK$884.57M total) Read: UBS crossing 5%+ on an ~HK$885M build points to real institutional demand, not a passive rebalancing blip.

🆕 NEW ENTRY — 780 Tongcheng Travel Holdings ← BlackRock, 5.35% (increased by 0.73pp from prior filing) Read: BlackRock's aggregate stake actually grew here despite the "ceased" paperwork tag — a genuine build across its fund complex.

🆕 NEW ENTRY — 1024 Kuaishou Technology ← BlackRock, 5.15% (increased by 0.19pp from prior filing) Read: Passive-fund aggregate ticking back above 5% suggests steady accumulation rather than a one-off flow.

🆕 NEW ENTRY — 6881 China Galaxy Securities ← BlackRock, 5.09% (increased by 0.16pp from prior filing) Read: A modest re-crossing of the 5% line as BlackRock's fund basket nets out slightly larger.

🆕 NEW ENTRY — 6821 Asymchem Laboratories (Tianjin) ← China Southern Asset Management, 5.05% (increased by 0.09pp from prior filing; small 25,000-share crossing trade @ HKD 140.25) Read: A mainland mega-manager just tipped over the 5% disclosure line on this CDMO name — a minor but notable institutional nod.

🆕 NEW ENTRY — 902 Huaneng Power International ← BlackRock, 5.06% (increased by 0.08pp from prior filing) Read: A thin re-crossing of 5% — index-fund bookkeeping more than a directional call on the utility.

🆕 NEW ENTRY — 697 Shoucheng Holdings ← Shoucheng Holdings (related entity), 5.00% (increased by 0.01pp from prior filing; tiny 900,000-share trade @ HKD 1.40) Read: Barely clearing the 5% threshold via a related-entity filing — a technical crossing with little standalone signal.

🏢 BUYBACK — 2145 Shanghai Chicmax Cosmetic ← BlackRock, 4.61% (decreased by 1.30pp from prior filing) Read: Chicmax's buyback is mechanically shrinking the float and shifting BlackRock's disclosed %, not a sign BlackRock is selling.

🏢 BUYBACK — 9927 Seres Group ← BlackRock, 4.35% (decreased by 1.04pp from prior filing) Read: Issuer buyback math is moving the stated %, not BlackRock's actual conviction in the AITO/EV maker.

🏢 BUYBACK — 1157 Zoomlion Heavy Industry ← BlackRock, 5.87% (decreased by 0.51pp from prior filing) Read: Another passive buyback-driven %-shift — no evidence of active trimming by BlackRock.

⚙️ OPTION/CONVERSION — 2533 Black Sesame International Holding ← Siyuan Dai, 4.84% (decreased by 1.40pp from prior filing; subscribed 7,738,200 new shares @ HKD 12.03 for HK$93.09M total; filed late, dated 2026-07-10) Read: An insider ploughing over HK$93M into a new-share subscription, though the enlarged base nets the stated stake lower.

⚙️ OPTION/CONVERSION — 2315 Biocytogen Pharmaceuticals ← China Merchants Bank International group (5 related entities incl. China Merchants Bank, CMB International Investment Management, Astral Eminent, CMBI Private Equity Series SPC), 8.81% (decreased by 1.10pp from prior filing; subscribed 1,221,000 new shares @ HKD 62.27 for HK$76.03M total) Read: A placement subscription funneled through CMB International's fund arm — the pp drop is dilution from the raise, not a sell-down.